JORDAN CARTER: Open Payments
NPI 1346804697 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 103 payments from 24 companies in 2025. Trend: 2023 $2,029 · 2024 $1,838 · 2025 $2,022
Food & beverage: $2,022
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 24 | $351 |
| Novo Nordisk Inc | 11 | $177 |
| Dexcom, Inc. | 3 | $174 |
| AstraZeneca Pharmaceuticals LP | 9 | $173 |
| Lilly USA, LLC | 9 | $146 |
| Merit Medical Systems Inc | 1 | $124 |
| Corium, LLC | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
Products named: NURTEC ODT, ELIQUIS, MOUNJARO, DEXCOM G7 GSS (161), ESOPHYX, Azstarys, Ozempic, Kerendia.
Industry payments across AL — which companies pay providers there.
